Skip to main content

GOLDMAN SACHS GROUP INC

Position in PTCT — Ptc Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$50,430,406
-$5,956,093 QoQ
Shares Held
618,247
-25.3% QoQ
Ownership
0.741%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#38
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Derivatives in PTCT

reported options exposure · as of Jun 30, 2020
CallValue
$1,395,350
CallShares
27,500
PutValue
$1,395,350
PutShares
27,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. PTCT ranks #64 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PTCT

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $50,430,406 618,247
2026-03-31 $56,386,499 827,631
2025-12-31 $77,713,992 1,023,091
2025-09-30 $53,785,219 876,409
2025-06-30 $37,887,776 775,753
2025-03-31 $30,711,807 602,665
2024-12-31 $34,515,172 764,625
2024-09-30 $30,512,560 822,441
2024-06-30 $24,193,794 791,164
2024-03-31 $13,963,809 480,021
2023-12-31 $14,510,174 526,494
2023-09-30 $7,616,844 339,886
2023-06-30 $17,334,855 426,232
2023-03-31 $21,927,915 452,682
2022-12-31 $20,345,907 533,034
2022-09-30 $25,374,995 505,478
2022-06-30 $19,876,970 496,180
2022-03-31 $8,521,865 228,407
2021-12-31 $21,003,672 527,333
2021-09-30 $8,492,028 228,219
2021-06-30 $11,383,902 269,314
2021-03-31 $24,342,776 514,103
2020-12-31 $43,141,496 706,890
2020-09-30 $18,000,199 385,031
2020-06-30 $1,395,350 27,500
2020-06-30 $43,679,275 860,845
2020-06-30 $1,395,350 27,500
2020-03-31 $26,843,843 601,745